Timothy E. Kennedy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Timothy E. Kennedy has a total of 356 co-authors. Here are the top co-authors by number of shared publications:
- Jack P. Antel
The Neuro (Montreal Neurological Institute-Hospital), QC, Canada
18 shared publications - Edward S. Ruthazer
Montreal Neurological Institute-Hospital, McGill University
9 shared publications - Stephen D. Glasgow
Department of Neurology & Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, H3A 2B4, Canada
9 shared publications Diane S. Nakamura
6 shared publicationsJenea M. Bin
Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montreal, QC, Canada, H3A 2B4
6 shared publicationsDaryan Chitsaz
McGill Program in Neuroengineering, Integrated Program in Neuroscience, Department of Neurology and Neurosurgery Montreal Neurological Institute, McGill University, 3801 University Street, Montreal H3A 2B4, Canada
5 shared publications
Latest Publications
- Open Access
- 9 February 2026
- Published by Frontiers Media SA in Frontiers in Synaptic Neuroscience
- Vol. 18, 1761008
Convergence and divergence of molecular mechanisms in Hebbian and homeostatic plasticity
The umbrella of synaptic plasticity includes associative, activity-dependent alterations in synaptic strength that are thought to underlie learning and memory, and negative feedback that stabilizes network activity, termed Hebbian and homeostatic plasticity, respectively. These forms of plasticity respond to activity oppositely, and on different spatial and temporal scales. However, despite these fundamental differences, many similar molecular mechanisms are engaged by each form of plasticity to alter synaptic strength. Here, we review molecular mechanisms involved in homeostatic plasticity and compare their involvement in Hebbian plasticity. We focus on synaptic scaling, long-term potentiation, and long-term depression, which are mediated by regulation of post-synaptic amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor (AMPARs) accumulation. Addressing synaptic scaffolding, intracellular signaling, cell-adhesion, and secreted factors, we identify mechanisms that appear to be convergent, differentially engaged, and divergent that uniquely regulate homeostatic scaling. These comparisons identify clear gaps to be addressed by future studies that aim to parse the contributions of Hebbian and homeostatic plasticity to regulate AMPAR function.
- 9 February 2026
- Published by Frontiers Media SA in Frontiers in Synaptic Neuroscience
- Vol. 18, 1761008
Open AccessConvergence and divergence of molecular mechanisms in Hebbian and homeostatic plasticity
The umbrella of synaptic plasticity includes associative, activity-dependent alterations in synaptic strength that are thought to underlie learning and memory, and negative feedback that stabilizes network activity, termed Hebbian and homeostatic plasticity, respectively. These forms of plasticity respond to activity oppositely, and on different spatial and temporal scales. However, despite these fundamental differences, many similar molecular mechanisms are engaged by each form of plasticity to alter synaptic strength. Here, we review molecular mechanisms involved in homeostatic plasticity and compare their involvement in Hebbian plasticity. We focus on synaptic scaling, long-term potentiation, and long-term depression, which are mediated by regulation of post-synaptic amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor (AMPARs) accumulation. Addressing synaptic scaffolding, intracellular signaling, cell-adhesion, and secreted factors, we identify mechanisms that appear to be convergent, differentially engaged, and divergent that uniquely regulate homeostatic scaling. These comparisons identify clear gaps to be addressed by future studies that aim to parse the contributions of Hebbian and homeostatic plasticity to regulate AMPAR function.
- Open Access
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (6) , e200313
Developing a National Network for Leukodystrophy Research and Care in Canada
Leukodystrophies (LDs) are a group of rare, genetic disorders unified by their hallmark involvement of the cerebral white matter. They are typically characterized as progressive disorders, resulting in severe neurologic decline and premature death within months to years after onset. Managing LDs therefore requires lifelong, multidisciplinary care, a challenge compounded by their rarity and phenotypic heterogeneity, for which detailed clinical and scientific information is sometimes lacking. Research networks have proven useful in the rare disease community to unite efforts, increase awareness, and accelerate progress toward understanding and treating these often understudied conditions. Therefore, we established the Canadian Association for Research Excellence in Leukodystrophy (CARELeuko), a national network dedicated to improving LD care, research, and treatment within Canada. To better understand and address the most pressing needs for LDs in Canada, we engaged a diverse group of stakeholders including researchers, clinicians, and patient advocates to highlight and prioritize gaps in LD care and research. In this review, we discuss the key gaps identified in the Canadian LD landscape and outline strategies to address these challenges. This effort will inform the development of targeted initiatives aimed at improving outcomes for Canadian families affected by these debilitating disorders.
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (6) , e200313
Open AccessDeveloping a National Network for Leukodystrophy Research and Care in Canada
Leukodystrophies (LDs) are a group of rare, genetic disorders unified by their hallmark involvement of the cerebral white matter. They are typically characterized as progressive disorders, resulting in severe neurologic decline and premature death within months to years after onset. Managing LDs therefore requires lifelong, multidisciplinary care, a challenge compounded by their rarity and phenotypic heterogeneity, for which detailed clinical and scientific information is sometimes lacking. Research networks have proven useful in the rare disease community to unite efforts, increase awareness, and accelerate progress toward understanding and treating these often understudied conditions. Therefore, we established the Canadian Association for Research Excellence in Leukodystrophy (CARELeuko), a national network dedicated to improving LD care, research, and treatment within Canada. To better understand and address the most pressing needs for LDs in Canada, we engaged a diverse group of stakeholders including researchers, clinicians, and patient advocates to highlight and prioritize gaps in LD care and research. In this review, we discuss the key gaps identified in the Canadian LD landscape and outline strategies to address these challenges. This effort will inform the development of targeted initiatives aimed at improving outcomes for Canadian families affected by these debilitating disorders.
- 15 November 2025
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (23) , 4511-4518
Characterization of Dendritic Polyglycerol Amine Layers as Coatings for Improved Neural Cell Growth Surfaces
Surfaces coated with the hyperbranched dendritic polyglycerol amine, dPGA, a nonprotein macromolecular biomimetic of polylysine, have been shown to provide enhanced support for stable long-term culture of embryonic rat neocortical neurons and human neurons derived from induced pluripotent stem cells (iPSCs). Here, we investigate the physical properties of surface-adsorbed dPGA to understand how it provides better support for cell attachment, survival, and growth. High-molecular-weight dPGA (MW 550 kDa) with ∼30% amine functionalization was deposited on silicon wafers from PBS (pH 7.4) solutions to measure the layer thickness and density by ellipsometry and surface roughness and texture by atomic force microscopy (AFM). Colloidal silica (dia ∼ 100 nm) was used as a substrate to measure surface charge (zeta potential), adsorbed amounts by thermal gravimetric analysis (TGA), and molecular mobility by solid-state NMR spectroscopy. We found that the dPGA film properties were dependent on the immersion time in the dPGA coating solution as well as the storage conditions of dPGA solutions. Upon immobilization, dPGA retains a globular but flattened shape. Chain mobility is reduced but the adsorbed dPGA still can be considered a highly flexible polymer that rearranges to present a higher density of positive surface charges as compared to dPGA in solution. Coated surfaces prepared with different deposition times were tested for the capacity to support cells in culture.
- 15 November 2025
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (23) , 4511-4518
Characterization of Dendritic Polyglycerol Amine Layers as Coatings for Improved Neural Cell Growth Surfaces
Surfaces coated with the hyperbranched dendritic polyglycerol amine, dPGA, a nonprotein macromolecular biomimetic of polylysine, have been shown to provide enhanced support for stable long-term culture of embryonic rat neocortical neurons and human neurons derived from induced pluripotent stem cells (iPSCs). Here, we investigate the physical properties of surface-adsorbed dPGA to understand how it provides better support for cell attachment, survival, and growth. High-molecular-weight dPGA (MW 550 kDa) with ∼30% amine functionalization was deposited on silicon wafers from PBS (pH 7.4) solutions to measure the layer thickness and density by ellipsometry and surface roughness and texture by atomic force microscopy (AFM). Colloidal silica (dia ∼ 100 nm) was used as a substrate to measure surface charge (zeta potential), adsorbed amounts by thermal gravimetric analysis (TGA), and molecular mobility by solid-state NMR spectroscopy. We found that the dPGA film properties were dependent on the immersion time in the dPGA coating solution as well as the storage conditions of dPGA solutions. Upon immobilization, dPGA retains a globular but flattened shape. Chain mobility is reduced but the adsorbed dPGA still can be considered a highly flexible polymer that rearranges to present a higher density of positive surface charges as compared to dPGA in solution. Coated surfaces prepared with different deposition times were tested for the capacity to support cells in culture.
- Open Access
- 27 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (44)
Characterization of endothelin-converting enzyme 1 as a key enzyme in the multienzyme Aβ degradation pathway
Altered β-amyloid (Aβ) homeostasis is a critical event triggering the shift from healthy aging to Alzheimer disease (AD) through the overproduction and impaired clearance of Aβ peptides. The Aβ-degrading enzymes (ADEs) are a collective group of proteases that normally promote clearance to counteract Aβ-induced neurodegeneration. We previously discovered that the beta-site amyloid precursor protein cleaving enzyme 1 is an atypical ADE that produces the nontoxic fragment Aβ34 by recognizing 40- or 42-residue-long Aβ peptides as substrates in vitro and in vivo. Here, we examined other known ADEs for their potential roles in degrading Aβ34, Aβ40, and Aβ42. By genetic, cellular, and pharmacological approaches, we identified and characterized endothelin-converting enzyme 1 (ECE1) in a human neuroblastoma cell line, human brain vascular pericytes, and primary rat cortical cultures as a major enzyme degrading Aβ34 but not Aβ40 or Aβ42. Notably, we found that ECE1 cleaves Aβ34, an indicator of amyloid clearance, to a unique and unusually stable Aβ20-34 fragment that has the potential to serve as a measurable biomarker. Biocomputational analyses from non-AD controls and individuals with AD pathology showed that the highest messenger ribonucleic acid (mRNA) levels of ECE1 expression were found in pericytes (i.e., cells within the brain microvasculature that are known to produce Aβ34) compared to other cell types. Given Aβ34 is an indicator for prodromal AD, we postulate that our collective findings (i.e., generation of Aβ34 and Aβ20-34 intermediates within the “amyloidolytic” degradation pathway) will generate a set of biomarkers to detect amyloid clearance activity in vivo.
- 27 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (44)
Open AccessCharacterization of endothelin-converting enzyme 1 as a key enzyme in the multienzyme Aβ degradation pathway
Altered β-amyloid (Aβ) homeostasis is a critical event triggering the shift from healthy aging to Alzheimer disease (AD) through the overproduction and impaired clearance of Aβ peptides. The Aβ-degrading enzymes (ADEs) are a collective group of proteases that normally promote clearance to counteract Aβ-induced neurodegeneration. We previously discovered that the beta-site amyloid precursor protein cleaving enzyme 1 is an atypical ADE that produces the nontoxic fragment Aβ34 by recognizing 40- or 42-residue-long Aβ peptides as substrates in vitro and in vivo. Here, we examined other known ADEs for their potential roles in degrading Aβ34, Aβ40, and Aβ42. By genetic, cellular, and pharmacological approaches, we identified and characterized endothelin-converting enzyme 1 (ECE1) in a human neuroblastoma cell line, human brain vascular pericytes, and primary rat cortical cultures as a major enzyme degrading Aβ34 but not Aβ40 or Aβ42. Notably, we found that ECE1 cleaves Aβ34, an indicator of amyloid clearance, to a unique and unusually stable Aβ20-34 fragment that has the potential to serve as a measurable biomarker. Biocomputational analyses from non-AD controls and individuals with AD pathology showed that the highest messenger ribonucleic acid (mRNA) levels of ECE1 expression were found in pericytes (i.e., cells within the brain microvasculature that are known to produce Aβ34) compared to other cell types. Given Aβ34 is an indicator for prodromal AD, we postulate that our collective findings (i.e., generation of Aβ34 and Aβ20-34 intermediates within the “amyloidolytic” degradation pathway) will generate a set of biomarkers to detect amyloid clearance activity in vivo.
- 24 August 2025
- Published by American Chemical Society (ACS) in ACS Nano
Molecular Biomimicry and the Synthetic Synapse: Engineering a Stable Synaptogenic Extracellular Matrix
Synapses are highly specialized sites of asymmetric cell-cell contact that mediate information transfer between neurons. Many proteins have been identified that contribute to the complex processes that underlie the formation, organization, and maintenance of synapses, and the molecular biology of synapse formation is increasingly well understood. Surprisingly, synaptic differentiation does not require a cellular target. Hemisynaptic specializations form quickly at sites of neurite adhesion to microspheres coated with a synaptogenic protein or a synthetic cationic polypeptide like polylysine. This raises the possibility that functional hemisynaptic connections could be directed to form onto engineered surfaces; however, studies examining the stability of synaptic specializations formed in the brain onto polylysine-coated beads found that they were unstable and degraded within a few weeks after implantation. Here, we demonstrate that microbeads coated with dendritic polyglycerol amine (dPGA), a nonprotein macromolecular biomimetic of polylysine, promote enhanced synaptogenesis and synapse stability compared to conventional polylysine. We show that a dPGA coating is stable in long-term cell culture, resisting proteolysis, and that dPGA-coated beads cluster neurexin, which is sufficient to direct presynaptic terminal formation. We propose that synthetic synaptogenic extracellular matrices that resist proteolysis could be used to engineer electrodes with enhanced neural biocompatibility and support long-term bidirectional communication with neurons by directing the formation of stable synaptic specializations.
- 24 August 2025
- Published by American Chemical Society (ACS) in ACS Nano
Molecular Biomimicry and the Synthetic Synapse: Engineering a Stable Synaptogenic Extracellular Matrix
Synapses are highly specialized sites of asymmetric cell-cell contact that mediate information transfer between neurons. Many proteins have been identified that contribute to the complex processes that underlie the formation, organization, and maintenance of synapses, and the molecular biology of synapse formation is increasingly well understood. Surprisingly, synaptic differentiation does not require a cellular target. Hemisynaptic specializations form quickly at sites of neurite adhesion to microspheres coated with a synaptogenic protein or a synthetic cationic polypeptide like polylysine. This raises the possibility that functional hemisynaptic connections could be directed to form onto engineered surfaces; however, studies examining the stability of synaptic specializations formed in the brain onto polylysine-coated beads found that they were unstable and degraded within a few weeks after implantation. Here, we demonstrate that microbeads coated with dendritic polyglycerol amine (dPGA), a nonprotein macromolecular biomimetic of polylysine, promote enhanced synaptogenesis and synapse stability compared to conventional polylysine. We show that a dPGA coating is stable in long-term cell culture, resisting proteolysis, and that dPGA-coated beads cluster neurexin, which is sufficient to direct presynaptic terminal formation. We propose that synthetic synaptogenic extracellular matrices that resist proteolysis could be used to engineer electrodes with enhanced neural biocompatibility and support long-term bidirectional communication with neurons by directing the formation of stable synaptic specializations.
- Open Access
Dendritic Polyglycerol Amine Substrate Extends the Viability of Mixed Glial Cultures for Repeated Isolation of Immature Oligodendrocyte Lineage Cells
Primary mixed glial cultures are key tools to isolate and study astrocytes, microglia and oligodendrocytes. Cell-substrate adhesion is critical for neural cell survival and differentiation. Cationic polymers like poly-D-lysine (PDL) are widely used to promote cell adhesion to cell culture substrates, however, PDL is not stable long-term, with cultured cells often detaching (peeling) after 2-3 weeks. Dendritic polyglycerol amine (dPGA) is a synthetic polycationic non-protein polymer biomimetic of poly-lysine that is highly resistant to degradation by cellular proteases. Substrates coated with dPGA promote cell adhesion and improve survival in long-term neuronal cultures. Here we assessed dPGA as a substrate coating to provide long-term support for mixed glial cultures. Oligodendrocyte precursor cells (OPCs) were isolated weekly by differential adhesion from cultures grown in T75 flasks with PDL or dPGA-coated substrates. Following two “shake-off” isolations, the cell layer in most PDL-coated flasks fully detached, rendering these flasks unusable for further culture. In contrast, dPGA-coated flasks consistently yielded cells for six or more sequential isolations over seven weeks in culture. dPGA-coated flasks produced more cells, a greater percentage of O4+ cells, and maintained similar proportions of OPCs and MBP-positive cells as when isolated from a PDL-coated substrate. dPGA is cyto-compatible, functionally superior, easy to use, low cost and a stable alternative to conventional cell substrate coatings. The enhanced long-term stability of mixed glial cultures grown on a dPGA substrate has the capacity to increase cellular yield, reduce animal use, and facilitate studies of oligodendrocyte cell biology.
Open AccessDendritic Polyglycerol Amine Substrate Extends the Viability of Mixed Glial Cultures for Repeated Isolation of Immature Oligodendrocyte Lineage Cells
Primary mixed glial cultures are key tools to isolate and study astrocytes, microglia and oligodendrocytes. Cell-substrate adhesion is critical for neural cell survival and differentiation. Cationic polymers like poly-D-lysine (PDL) are widely used to promote cell adhesion to cell culture substrates, however, PDL is not stable long-term, with cultured cells often detaching (peeling) after 2-3 weeks. Dendritic polyglycerol amine (dPGA) is a synthetic polycationic non-protein polymer biomimetic of poly-lysine that is highly resistant to degradation by cellular proteases. Substrates coated with dPGA promote cell adhesion and improve survival in long-term neuronal cultures. Here we assessed dPGA as a substrate coating to provide long-term support for mixed glial cultures. Oligodendrocyte precursor cells (OPCs) were isolated weekly by differential adhesion from cultures grown in T75 flasks with PDL or dPGA-coated substrates. Following two “shake-off” isolations, the cell layer in most PDL-coated flasks fully detached, rendering these flasks unusable for further culture. In contrast, dPGA-coated flasks consistently yielded cells for six or more sequential isolations over seven weeks in culture. dPGA-coated flasks produced more cells, a greater percentage of O4+ cells, and maintained similar proportions of OPCs and MBP-positive cells as when isolated from a PDL-coated substrate. dPGA is cyto-compatible, functionally superior, easy to use, low cost and a stable alternative to conventional cell substrate coatings. The enhanced long-term stability of mixed glial cultures grown on a dPGA substrate has the capacity to increase cellular yield, reduce animal use, and facilitate studies of oligodendrocyte cell biology.
- Open Access
- 6 May 2025
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (6) , 2319-2320
Energy for myelination: Implications for metabolic disturbances in multiple sclerosis pathology
An abstract is unavailable. This article is available as a PDF only.
- 6 May 2025
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (6) , 2319-2320
Open AccessEnergy for myelination: Implications for metabolic disturbances in multiple sclerosis pathology
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 3 April 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (4) , e70308
Multiplex Immunofluorescent Batch Labeling of Marmoset Brain Sections
Purpose: The common marmoset is a small nonhuman primate that has emerged as a valuable animal model in neuroscience research. Accurate analysis of brain tissue is crucial to understand marmoset neurophysiology and to model neurodegenerative diseases. Many studies to date have complemented magnetic resonance imaging (MRI) with histochemical staining rather than immunofluorescent labeling, which can generate more informative and higher resolution images. There is a need for high‐throughput immunolabeling and imaging methodologies to generate resources for the burgeoning marmoset field, particularly brain histology atlases to display the organization of different cell types and other structures.Methods and Findings: Here, we have characterized a set of marmoset‐compatible fluorescent dyes and antibodies that label myelin, axons, dendrites, and the iron‐storage protein ferritin, and developed a batch‐style multiplex immunohistochemistry protocol to uniformly process large numbers of tissue slides for multiple cell‐type specific markers.Conclusion: We provide a practical guide for researchers interested in harnessing the potential of marmoset models to advance understanding of brain structure, function, and pathophysiology.
- 3 April 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (4) , e70308
Open AccessMultiplex Immunofluorescent Batch Labeling of Marmoset Brain Sections
Purpose: The common marmoset is a small nonhuman primate that has emerged as a valuable animal model in neuroscience research. Accurate analysis of brain tissue is crucial to understand marmoset neurophysiology and to model neurodegenerative diseases. Many studies to date have complemented magnetic resonance imaging (MRI) with histochemical staining rather than immunofluorescent labeling, which can generate more informative and higher resolution images. There is a need for high‐throughput immunolabeling and imaging methodologies to generate resources for the burgeoning marmoset field, particularly brain histology atlases to display the organization of different cell types and other structures.Methods and Findings: Here, we have characterized a set of marmoset‐compatible fluorescent dyes and antibodies that label myelin, axons, dendrites, and the iron‐storage protein ferritin, and developed a batch‐style multiplex immunohistochemistry protocol to uniformly process large numbers of tissue slides for multiple cell‐type specific markers.Conclusion: We provide a practical guide for researchers interested in harnessing the potential of marmoset models to advance understanding of brain structure, function, and pathophysiology.
- Open Access
- 10 September 2024
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (1)
From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease
Mature myelinating oligodendrocytes, the cells that produce the myelin sheath that insulates axons in the central nervous system, have distinct energetic and metabolic requirements compared to neurons. Neurons require substantial energy to execute action potentials, while the energy needs of oligodendrocytes are directed toward building the lipid‐rich components of myelin and supporting neuronal metabolism by transferring glycolytic products to axons as additional fuel. The utilization of energy metabolites in the brain parenchyma is tightly regulated to meet the needs of different cell types. Disruption of the supply of metabolites can lead to stress and oligodendrocyte injury, contributing to various neurological disorders, including some demyelinating diseases. Understanding the physiological properties, structures, and mechanisms involved in oligodendrocyte energy metabolism, as well as the relationship between oligodendrocytes and neighboring cells, is crucial to investigate the underlying pathophysiology caused by metabolic impairment in these disorders. In this review, we describe the particular physiological properties of oligodendrocyte energy metabolism and the response of oligodendrocytes to metabolic stress. We delineate the relationship between oligodendrocytes and other cells in the context of the neurovascular unit, and the regulation of metabolite supply according to energetic needs. We focus on the specific bioenergetic requirements of oligodendrocytes and address the disruption of metabolic energy in demyelinating diseases. We encourage further studies to increase understanding of the significance of metabolic stress on oligodendrocyte injury, to support the development of novel therapeutic approaches for the treatment of demyelinating diseases. image
- 10 September 2024
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (1)
Open AccessFrom BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease
Mature myelinating oligodendrocytes, the cells that produce the myelin sheath that insulates axons in the central nervous system, have distinct energetic and metabolic requirements compared to neurons. Neurons require substantial energy to execute action potentials, while the energy needs of oligodendrocytes are directed toward building the lipid‐rich components of myelin and supporting neuronal metabolism by transferring glycolytic products to axons as additional fuel. The utilization of energy metabolites in the brain parenchyma is tightly regulated to meet the needs of different cell types. Disruption of the supply of metabolites can lead to stress and oligodendrocyte injury, contributing to various neurological disorders, including some demyelinating diseases. Understanding the physiological properties, structures, and mechanisms involved in oligodendrocyte energy metabolism, as well as the relationship between oligodendrocytes and neighboring cells, is crucial to investigate the underlying pathophysiology caused by metabolic impairment in these disorders. In this review, we describe the particular physiological properties of oligodendrocyte energy metabolism and the response of oligodendrocytes to metabolic stress. We delineate the relationship between oligodendrocytes and other cells in the context of the neurovascular unit, and the regulation of metabolite supply according to energetic needs. We focus on the specific bioenergetic requirements of oligodendrocytes and address the disruption of metabolic energy in demyelinating diseases. We encourage further studies to increase understanding of the significance of metabolic stress on oligodendrocyte injury, to support the development of novel therapeutic approaches for the treatment of demyelinating diseases. image